clinical implications of ctcs in prostate cancer – are they the best thing to measure?
Published 7 years ago • 126 plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
1:25
potential of ctcs for biomarker detection in prostate cancer
-
1:19
what is the potential of circulating tumor cells (ctcs) as a marker for cancer?
-
1:30
how far away are we from implementing ctc-based approaches in prostate cancer?
-
0:33
circulating tumor cells in management of patients with castration-resistant prostate cancer
-
18:07
molecular analysis of ctcs in prostate cancer
-
0:31
unmet needs in the use of circulating tumor cells for prostate cancer
-
30:17
circulating tumor cells in prostate cancer - the premise and the promise
-
18:07
molecular analysis of ctcs in prostate cancer
-
3:56
ctc enumeration as a prognostic biomarker in prostate cancer
-
6:13
analysis of circulating prostate cancer tumor cells
-
26:54
fluciclovine (18f) pet/ct impact on clinical management of recurrent prostate cancer
-
6:01
clinical utility of circulating tumor cells
-
6:25
ctc subtypes and prostate cancer progression
-
2:39
circulating tumour cells (ctcs): tracking the spread of cancer
-
49:24
siegfried hauch-the molecular analysis on circulating tumor cells to determine prognostic and predic
-
2:50
ctc counts using epic sciences for mcrpc
-
1:03:52
circulating tumor cells clinical utility, challenges and future prospects
-
6:42
q&a "can the circulating tumor cell (ctc) chip be used in cancer screening?"
-
2:18
practical recommendations for circulating tumor cells in prostate cancer